4-Aminopyrazolo[3,4-d]pyrimidine structure
|
Common Name | 4-Aminopyrazolo[3,4-d]pyrimidine | ||
---|---|---|---|---|
CAS Number | 2380-63-4 | Molecular Weight | 193.671 | |
Density | 1.612g/cm3 | Boiling Point | 431.1ºC at 760mmHg | |
Molecular Formula | C5H5N5 | Melting Point | >325 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 244.4ºC | |
Symbol |
GHS06 |
Signal Word | Danger |
Use of 4-Aminopyrazolo[3,4-d]pyrimidinePyrazoloadenine is a potent RET (REarranged during Transfection) lung cancer oncoprotein inhibitor. Pyrazoloadenine shows anticancer activity[1][2]. |
Name | 4-Aminopyrazolo[3,4-d]pyrimidine |
---|---|
Synonym | More Synonyms |
Description | Pyrazoloadenine is a potent RET (REarranged during Transfection) lung cancer oncoprotein inhibitor. Pyrazoloadenine shows anticancer activity[1][2]. |
---|---|
Related Catalog | |
In Vitro | Pyrazoloadenine inhibits a wide range of protein kinases such as BTK (Bruton’s tyrosine kinase), CDK1/2 (cyclin-dependent kinase 1/2), Src kinase, and RIPK1 (receptor-interacting protein kinase)[1]. |
Density | 1.612g/cm3 |
---|---|
Boiling Point | 431.1ºC at 760mmHg |
Melting Point | >325 °C(lit.) |
Molecular Formula | C5H5N5 |
Molecular Weight | 193.671 |
Flash Point | 244.4ºC |
Exact Mass | 193.086960 |
PSA | 80.48000 |
LogP | 0.51630 |
Storage condition | -20°C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H315-H319-H335 |
Precautionary Statements | P261-P301 + P310-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic; |
Risk Phrases | R23/24/25;R36/37/38 |
Safety Phrases | S26-S36/37/39-S45-S22 |
RIDADR | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | UR0717000 |
Packaging Group | III |
Hazard Class | 6.1 |
HS Code | 2933990090 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus.
J. Neurosci. 35(11) , 4540-51, (2015) The dorsal cochlear nucleus (DCN) is one of the first stations within the central auditory pathway where the basic computations underlying sound localization are initiated and heightened activity in t... |
|
Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival.
J. Clin. Invest. 124(6) , 2585-98, (2014) Activation of the ER stress response is associated with malignant progression of B cell chronic lymphocytic leukemia (CLL). We developed a murine CLL model that lacks the ER stress-associated transcri... |
|
Spectroscopic, electronic structure and natural bond analysis of 2-aminopyrimidine and 4-aminopyrazolo[3,4-d]pyrimidine: a comparative study.
Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 96 , 226-41, (2012) The FTIR and FT-Raman spectra of 2-aminopyrimidine (2-AP) and 4-aminopyrazolo[3,4-d]pyrimidine (4-APP) has been recorded in the region 4000-400 and 3500-100 cm(-1), respectively. The tautomeric stabil... |
Methyl 3-piperidinylacetate hydrochloride (1:1) |
7-deaza-8-aza-adenine |
8-aza-7-deazaadenine |
1H-Pyrazolo[3,4-d]pyrimidin-4-amine |
1H-pyrazolo[3,4-d]pyrimidin-4-ylamine |
EINECS 219-174-6 |
pyrazolo[3,4-d]pyrimidin-4-amine |
Pyrazoloadenine |
Aminopurinol |
4-aminopyrazolo-(3,4-d)pyrimidine |
4-aminopyrazolo[5,4-d]pyrimidine |
4-Aminopyrazolopyrimidine |
1H-Pyrazolo[3,4-d]pyrimidine-4-ylamine 4-Amino-1H-pyrazolo[3,4-d]pyrimidine |
Pyrazolo[3,4-d]pyrimidin-4-amin |
4-app |
ADENINE ANTIMETABOLITE |
MFCD00005688 |
3-Piperidineacetic acid, methyl ester, hydrochloride (1:1) |
4-AMINOPYRAZOLO{3,4-D}PYRIMIDINE |
1(H)-4-amine-pyrazolo[3,4-d]pyrimidine |
4-Amino pyrazolo[3,4-d]pyrimidine |